Related Experiment Video
Updated: Sep 27, 2026

Oxygen-Independent Assays to Measure Mitochondrial Function in Mammals
Published on: May 19, 2023
Peroxisome proliferative drugs do not induce an increase of rat mevalonate pyrophosphate decarboxylase
Akihiro Michihara1, Makoto Sawamura, Yukio Yamori
1Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Gakuencho, Fukuyama, Hiroshima 729-0292, Japan. mitihara@fupharm.fukuyama-u.ac.jp
Abstract:
To determine whether or not the expression of mevalonate pyrophosphate decarboxylase (MPD) depends on the proliferation of peroxisomes, we examined change in the protein level of MPD in the crude extract, the cytosol and the peroxisome-enriched fraction of the livers of rats administered peroxisome proliferative drugs. No increase of MPD was observed in any of these fractions. These data suggest that the expression of MPD is independent of the proliferation of peroxisomes and may be maintained via a specific regulatory mechanism different from that of the expression of peroxisome proliferator-activated receptor alpha.
Insights
The expression of mevalonate pyrophosphate decarboxylase (MPD) is not linked to peroxisome proliferation. MPD levels remain unchanged even when peroxisome proliferation is induced, suggesting a distinct regulatory pathway.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Regulation
Background:
- Peroxisome proliferator-activated receptor alpha (PPARα) is a key regulator of peroxisome proliferation.
- The relationship between peroxisome proliferation and the expression of mevalonate pyrophosphate decarboxylase (MPD) has not been fully elucidated.
- Understanding MPD regulation is crucial for comprehending metabolic pathways.
Purpose of the Study:
- To investigate if mevalonate pyrophosphate decarboxylase (MPD) expression is dependent on peroxisome proliferation.
- To determine the regulatory mechanisms governing MPD expression in response to peroxisome proliferative stimuli.
Main Methods:
- Administered peroxisome proliferative drugs to rats.
- Examined MPD protein levels in liver crude extract, cytosol, and peroxisome-enriched fractions.
- Utilized biochemical assays to quantify protein levels.
Main Results:
- No significant increase in MPD protein levels was observed in any of the analyzed liver fractions (crude extract, cytosol, peroxisome-enriched).
- MPD expression did not correlate with the induced proliferation of peroxisomes.
- The results indicate that MPD regulation differs from that of PPARα.
Conclusions:
- Mevalonate pyrophosphate decarboxylase (MPD) expression is independent of peroxisome proliferation.
- MPD regulation likely involves specific mechanisms distinct from those controlling PPARα.
- Further research is needed to identify the precise regulatory pathway for MPD.
Related Concept Videos
Peroxisomes
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...

